Original language | English |
---|---|
Pages (from-to) | 446 - 447 |
Number of pages | 2 |
Journal | Blood |
Volume | 114 |
Issue number | 22 |
Publication status | Published - 2009 |
Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment.
Judith C. W. Marsh, Vikas Gupta, ZiYi Lim, David Marks, Edward C. Gordon-Smith, Ghulam J. Mufti
Research output: Contribution to journal › Meeting abstract